IN2014KN01374A - - Google Patents
Info
- Publication number
- IN2014KN01374A IN2014KN01374A IN1374KON2014A IN2014KN01374A IN 2014KN01374 A IN2014KN01374 A IN 2014KN01374A IN 1374KON2014 A IN1374KON2014 A IN 1374KON2014A IN 2014KN01374 A IN2014KN01374 A IN 2014KN01374A
- Authority
- IN
- India
- Prior art keywords
- resistance
- cells
- identification
- generation
- cell cultures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11191408.1A EP2599859A1 (fr) | 2011-11-30 | 2011-11-30 | Cellules haploïdes |
US201161565626P | 2011-12-01 | 2011-12-01 | |
PCT/EP2012/074112 WO2013079670A1 (fr) | 2011-11-30 | 2012-11-30 | Cellules haploïdes |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014KN01374A true IN2014KN01374A (fr) | 2015-10-16 |
Family
ID=45218335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1374KON2014 IN2014KN01374A (fr) | 2011-11-30 | 2012-11-30 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20140342369A1 (fr) |
EP (2) | EP2599859A1 (fr) |
JP (1) | JP2015500637A (fr) |
KR (1) | KR20140101390A (fr) |
CN (1) | CN104024404A (fr) |
AU (1) | AU2012343826A1 (fr) |
CA (1) | CA2856810A1 (fr) |
IL (1) | IL232879A0 (fr) |
IN (1) | IN2014KN01374A (fr) |
SG (1) | SG11201402350QA (fr) |
WO (1) | WO2013079670A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2629285T5 (es) | 2011-03-02 | 2020-07-23 | Anton Wutz | Células madre embrionarias haploides de mamífero |
WO2015152146A1 (fr) * | 2014-03-31 | 2015-10-08 | 国立大学法人東京医科歯科大学 | Procédé de culture de cellules souches embryonnaires haploïdes |
CA2993476A1 (fr) | 2015-07-29 | 2017-02-02 | New York Stem Cell Foundation, Inc. | Lignees de cellules souches embryonnaires humaines haploides et lignees de cellules somatiques humaines haploides et procedes de production de celles-ci |
US11859232B2 (en) | 2016-06-19 | 2024-01-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Screening for chemotherapy resistance in human haploid cells |
US11608570B2 (en) | 2016-07-29 | 2023-03-21 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Targeted in situ protein diversification by site directed DNA cleavage and repair |
EP3388530A1 (fr) | 2017-04-13 | 2018-10-17 | IMBA-Institut für Molekulare Biotechnologie GmbH | Modification et procédé d'identification d'acide nucléique |
CA3058540A1 (fr) | 2017-04-13 | 2018-10-18 | Imba - Institut Fur Molekulare Biotechnologie Gmbh | Modification d'acide nucleique et procede d'identification |
CN108998410B (zh) * | 2017-06-07 | 2020-11-06 | 中国科学院动物研究所 | 蛋白激酶抑制剂在抑制单倍体细胞二倍化中的用途 |
CN107217042B (zh) * | 2017-07-31 | 2020-03-06 | 江苏东抗生物医药科技有限公司 | 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法 |
US10626319B1 (en) | 2019-05-17 | 2020-04-21 | King Fahd University Of Petroleum And Minerals | Methods of inhibiting corrosion with a pyrazine corrosion inhibitor |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
EP1092768A1 (fr) | 1999-10-16 | 2001-04-18 | ARTEMIS Pharmaceuticals GmbH | Construction pour le piègeage conditionel et la disruption de gènes |
AU782846B2 (en) | 1999-10-28 | 2005-09-01 | University Of Massachusetts | Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
CA2388510A1 (fr) | 1999-11-02 | 2001-05-10 | James M. Robl | Utilisation de genomes haploides a des fins genetiques de diagnostic, de modification et de multiplication |
US7074611B2 (en) | 2001-04-27 | 2006-07-11 | Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie) | Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof |
US7235654B2 (en) | 2002-12-09 | 2007-06-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods for modulating IKKα activity |
DK2457999T3 (en) | 2002-12-16 | 2019-02-11 | Technion Res & Dev Foundation | CULTIVATION MEDIUM FOR PLURIPOTENT STEM CELLS |
EP1662005A1 (fr) | 2004-11-26 | 2006-05-31 | FrankGen Biotechnologie AG | Vecteurs pièges contenant au moins un enhancer et adéquats pour un "gene trapping" aléatoire ou ciblé |
DK1815001T3 (da) | 2004-11-26 | 2011-05-16 | Helmholtz Zentrum Muenchen | Genfældekassetter til tilfældig og målrettet konditioneret geninaktivering |
US20100069251A1 (en) | 2006-09-15 | 2010-03-18 | Children's Medical Center Corporation | Methods for producing embryonic stem cells from parthenogenetic embryos |
US20080299091A1 (en) * | 2007-04-06 | 2008-12-04 | International Stem Cell Corporation | Patient-specific stem cell lines derived from human parthenogenetic blastocysts |
ES2629285T5 (es) * | 2011-03-02 | 2020-07-23 | Anton Wutz | Células madre embrionarias haploides de mamífero |
-
2011
- 2011-11-30 EP EP11191408.1A patent/EP2599859A1/fr not_active Withdrawn
-
2012
- 2012-11-30 WO PCT/EP2012/074112 patent/WO2013079670A1/fr active Application Filing
- 2012-11-30 IN IN1374KON2014 patent/IN2014KN01374A/en unknown
- 2012-11-30 CN CN201280065785.XA patent/CN104024404A/zh active Pending
- 2012-11-30 AU AU2012343826A patent/AU2012343826A1/en not_active Abandoned
- 2012-11-30 SG SG11201402350QA patent/SG11201402350QA/en unknown
- 2012-11-30 EP EP12791811.8A patent/EP2785832A1/fr not_active Withdrawn
- 2012-11-30 US US14/361,655 patent/US20140342369A1/en not_active Abandoned
- 2012-11-30 JP JP2014543917A patent/JP2015500637A/ja active Pending
- 2012-11-30 KR KR1020147017705A patent/KR20140101390A/ko not_active Application Discontinuation
- 2012-11-30 CA CA2856810A patent/CA2856810A1/fr not_active Abandoned
-
2014
- 2014-05-29 IL IL232879A patent/IL232879A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2015500637A (ja) | 2015-01-08 |
EP2785832A1 (fr) | 2014-10-08 |
AU2012343826A1 (en) | 2014-06-12 |
CA2856810A1 (fr) | 2013-06-06 |
IL232879A0 (en) | 2014-07-31 |
EP2599859A1 (fr) | 2013-06-05 |
US20140342369A1 (en) | 2014-11-20 |
SG11201402350QA (en) | 2014-06-27 |
KR20140101390A (ko) | 2014-08-19 |
CN104024404A (zh) | 2014-09-03 |
WO2013079670A1 (fr) | 2013-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014KN01374A (fr) | ||
MY183741A (en) | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair | |
NZ627373A (en) | Genes involved in noscapine production | |
MX2014012994A (es) | Direccion transmitida por nucleasa con vectores de direccion grandes. | |
IL252045B (en) | Isolated nucleic acid, expression vector and cell culture comprising the nucleic acid | |
EA024121B9 (ru) | Композиции эндорибонуклеаз и способы их использования | |
MX2019010226A (es) | Composiciones de nanoparticulas lipidicas y metodos para administracion de arnm. | |
EP2545182A4 (fr) | Molécules polynucléotidiques pour régulation génique dans les végétaux | |
SG10201809901SA (en) | Generating Pluripotent Cells De Novo | |
HK1188466A1 (en) | Plant derived cell culture material | |
NZ628549A (en) | Novel class of glyphosate resistance genes | |
PH12015500213A1 (en) | Production of fmdv-resistant livestock by allele substitution | |
MX2011011508A (es) | Vector genico. | |
IN2014DN10996A (fr) | ||
MX2023003672A (es) | Composiciones y metodos para inhibir la expresion del gen de alfa-1 antitripsina. | |
MX2013007689A (es) | Moleculas de acido nucleico que confieren resistencia a pestes de coleopteran. | |
ZA201202814B (en) | Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis | |
MX356625B (es) | Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva. | |
MX2014000301A (es) | Métodos para mejorar el rendimiento y la tolerancia al estrés es una planta. | |
WO2012142116A3 (fr) | Identification et utilisation de mutants de krp dans le blé | |
IN2015KN00073A (fr) | ||
MY191390A (en) | Methods and compositions for increasing efficiency of increased efficiency of targeted gene modification using oligonucleotide-mediated gene repair | |
MX368901B (es) | Interferencia de la represion del factor de transcripcion hd-zip de expresion genica para la produccion de plantas con rasgos mejorados. | |
EP2707479A4 (fr) | Utilisation de zscan4 et gènes dépendant de zscan4 pour reprogrammation directe de cellules somatiques | |
IN2012DN01604A (fr) |